Lebenslauf Dr. Claudia Arndt
Positions
| since 2020 | Mildred-Scheel-Nachwuchszentrum (MSNZ) research group leader and staff scientist at Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research |
| 2015-2020 | Postdoc at the Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research |
Education
| 2010-2014 | Doctorate in Tumor Immunology, Institute of Immunology, Technical University Dresden |
| 2005-2010 | Study of Biology, Technische Universität Dresden |
Honors
| 2019 | American Society of Immunotherapy in Cancer (SITC), Young Investigator Award |
| 2010 | Diploma awarded with highest distinction from the TU Dresden |
Memberships
| since 2024 |
spokesperson of study group “Tumor Immunology” https://dgfi.org/arbeitskreise/ak-tumorimmunologie/ |
| 2021-2026 | WP consultant, “MHELTHERA” International Lab, Helmholtz Initiative and Networking Fund |
| since 2021 | Immunology & Inflammation (I&I) consortium, Helmholtz Association |
| since 2015 |
German Society of Immunology (DGfI) |
Funding
| 2025-2027 |
Wilhelm Sander-Stiftung „Hemmung der Antitumor-Immunantwort in Plattenepithelkarzinomen im Kopf- und Halsbereich (HNSCC) durch CD98hc-vermittelte metabolische Reprogrammierung“ |
| 2025 | Internal Funding, Medical Faculty, University Hospital Carl Gustav Carus, TU Dresden |
| 2023-2027 | Horizon EIC Pathfinder Challenges Network “B-specific” |
| 2022-2026 | Horizon Europe MSCA Doctoral Network “TOLERATE” |
| 2022-2026 |
Horizon Europe MSCA Doctoral Network “OncoProTools” |
| 2020-2026 |
MSNZ Dresden/German Cancer Aid (DKH): Personalisierte Karriereentwicklung in der Präzisionsonkologie: P2 Project |
| 2019-2022 | NCT Dresden-Translational Research Grant in Precision Oncology |